Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Discover ways to give back while enjoying your community. This guide pairs volunteering opportunities with free events to help you do more for less.
28,655 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Planning for retirement as a couple means more than just saving. This guide shows you how to protect your social secu...
A growing scam targets seniors through fake tech support calls, threatening retirement security. This guide explains ...
French authorities report a rising wave of wrench-style attacks targeting crypto holders, prompting arrests and a nat...
The United States says it has sent a 15-point cease-fire proposal to Iran, but Tehran has not confirmed receipt. As d...
A major investment advisor just boosted its stake in the Invesco BulletShares 2027 Corporate Bond ETF by about $76 mi...
When spacex just days away sparks market chatter, investors want to know what typically happens next. This guide brea...
SpaceX hit the market with a bang, as spacex stock climbed first in its debut week. This analysis looks at what histo...
A tech-focused ETF concentrates 32.8% of its holdings in four giants. Learn what this means for potential gains, risk...
As the fed's preferred inflation metric climbs above 4%, investors face questions about rate paths and portfolio reso...
A brutal European summer is forcing households to grapple with bigger energy bills and rising health costs as heat wa...
Travelers are receiving emails that imitate real reservations, complete with names, dates, and confirmation numbers. ...